Результати пошуку - Xin‐Ran Tang

  • Показ 1 - 12 результатів із 12
Уточнити результати
  1. 1
    Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma

    Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma за авторством Ying‐Qin Li, Xin-Ran Tang, Qing‐Mei He, Xiaojing Yang, Xianyue Ren, Xin Wen, Jian Zhang, Yaqin Wang, Na Liu, Jun Ma

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  2. 2
    MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma

    MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma за авторством Xin-Ran Tang, Xin Wen, Qing-Mei He, Ying-Qin Li, Xianyue Ren, Xiao-Jing Yang, Jian Zhang, Yaqin Wang, Jun Ma, Na Liu

    Опубліковано 2017
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways

    miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways за авторством Qing‐Mei He, Xianyue Ren, Jiewei Chen, Ying‐Qin Li, Xin-Ran Tang, Xin Wen, Xiaojing Yang, Jian Zhang, Yaqin Wang, Jun Ma, Na Liu

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    YPEL3 suppresses epithelial–mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway

    YPEL3 suppresses epithelial–mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway за авторством Jiän Zhang, Xin Wen, Xianyue Ren, Ying-Qin Li, Xin-Ran Tang, Yaqin Wang, Qing-Mei He, Xiao-Jing Yang, Ying Sun, Na Liu, Jun Ma

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma

    EZH2-DNMT1-mediated epigenetic silencing of miR-142-3p promotes metastasis through targeting ZEB2 in nasopharyngeal carcinoma за авторством Ying‐Qin Li, Qing‐Mei He, Xin Wen, Xiao-Hong Hong, Xiaojing Yang, Xin-Ran Tang, Panpan Zhang, Lei Yuan, Ying Sun, Jiän Zhang, Yaqin Wang, Jun Ma, Na Liu

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Hypermethylation of <i>SHISA3</i> Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability

    Hypermethylation of <i>SHISA3</i> Promotes Nasopharyngeal Carcinoma Metastasis by Reducing SGSM1 Stability за авторством Jiän Zhang, Ying-Qin Li, Rui Guo, Yaqin Wang, Panpan Zhang, Xin-Ran Tang, Xin Wen, Xiao-Hong Hong, Lei Yuan, Qing-Mei He, Xiao-Jing Yang, Ying Sun, Jun Ma, Na Liu

    Опубліковано 2018
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma

    HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma за авторством Xianyue Ren, Xiaojing Yang, Bin Cheng, Xiaozhong Chen, Tianpeng Zhang, Qing‐Mei He, Bin Li, Ying‐Qin Li, Xin-Ran Tang, Xin Wen, Qian Zhong, Tiebang Kang, Mu‐Sheng Zeng, Na Liu, Jun Ma

    Опубліковано 2017
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

    Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer за авторством Li Liu, Xue Bai, Jian Wang, Xin-Ran Tang, Dehua Wu, Shasha Du, Xiuju Du, Yaowei Zhang, Hongbo Zhu, Yuan Fang, Ze-Qin Guo, Qin Zeng, Xue‐Jun Guo, Zhu Liu, Zhong‐Yi Dong

    Опубліковано 2019
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

    Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study за авторством Xue Bai, Dehua Wu, Si-Cong Ma, Jian Wang, Xin-Ran Tang, Shuai Kang, Qiang Fu, Chuanhui Cao, He-San Luo, Yuhan Chen, Hongbo Zhu, Hong‐Hong Yan, Yi‐Long Wu, Zhong‐Yi Dong

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy

    CDK4/6 inhibition triggers ICAM1-driven immune response and sensitizes LKB1 mutant lung cancer to immunotherapy за авторством Xue Bai, Ze-Qin Guo, Yan-Pei Zhang, Zhenzhen Fan, Lijuan Liu, Li Liu, Li-Li Long, Si-Cong Ma, Jian Wang, Yuan Fang, Xin-Ran Tang, Yujie Zeng, Xinghua Pan, Dehua Wu, Zhong‐Yi Dong

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study

    Prognostic significance of tumor-infiltrating lymphocytes in nondisseminated nasopharyngeal carcinoma: A large-scale cohort study за авторством Yaqin Wang, Yu‐Pei Chen, Yu Zhang, Wei Jiang, Na Liu, Jing‐Ping Yun, Ying Sun, Qing‐Mei He, Xin‐Ran Tang, Xin Wen, Xiaojing Yang, Panpan Zhang, Jian Zhang, Lei Yuan, Ying‐Qin Li, Jun Ma

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study

    Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi‐center, single‐arm, open‐label, phase 2 study за авторством Wei Xu, Keshu Zhou, Tingyu Wang, Shenmiao Yang, Lihong Liu, Yu Hu, Wei Zhang, Kaiyang Ding, Jianfeng Zhou, Sujun Gao, Bing Xu, Zunmin Zhu, Ting Liu, Huilai Zhang, Jianda Hu, Chunyan Ji, Shunqing Wang, Zhongjun Xia, Xin Wang, Yan Li, Yongping Song, Shuo Ma, Xin‐Ran Tang, Bin Zhang, Jianyong Li

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: